| Stage | ADP | % of rev | PEGA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.5B | 100.00% | $393M | 100.00% | ADP ×13.96 |
| Gross profit | $2.8B | 50.57% | $290M | 73.60% | PEGA +23.0pp |
| Operating income | $1.5B | 26.64% | $15M | 3.78% | ADP +22.9pp |
| Pre-tax income | $1.5B | 26.50% | $18M | 4.52% | ADP +22.0pp |
| Net income | $1.1B | 20.49% | $14M | 3.58% | ADP +16.9pp |
| Stage | ADP | PEGA | Gap · A − B |
|---|---|---|---|
| Revenue | $5.5B100.00% | $393M100.00% | ADP ×13.96 |
| Gross profit | 50.57%$2.8B | 73.60%$290M | PEGA +23.0pp |
| Operating income | 26.64%$1.5B | 3.78%$15M | ADP +22.9pp |
| Pre-tax income | 26.50%$1.5B | 4.52%$18M | ADP +22.0pp |
| Net income |
| 20.49%$1.1B |
| 3.58%$14M |
| ADP +16.9pp |
No shared counterparties.